New phosphatidylinositol 3-kinase inhibitors for cancer-Reference-Cited by-同舟云学术

New phosphatidylinositol 3-kinase inhibitors for cancer

Published:2011-03-14 Issue:4 Volume:20 Page:507-518
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Bowles Daniel W¹,Jimeno Antonio²

Affiliation:

1. University of Colorado Comprehensive Cancer Center, 12801 E. 17th Ave, MS 8117, Aurora, CO 80045, USA

2. University of Colorado Comprehensive Cancer Center & Charles C. Gates Center of Stem Cell Biology, 12801 E. 17th Ave, MS 8117, Aurora, CO 80045, USA

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.2011.562192

Reference112 articles.

1. Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol.

2. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

3. PI3K pathway alterations in cancer: variations on a theme

4. Cellular Function of Phosphoinositide 3-Kinases: Implications for Development, Immunity, Homeostasis, and Cancer

5. High Frequency of Mutations of the PIK3CA Gene in Human Cancers

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review;Cancer and Metastasis Reviews;2023-10-04

2. Deoxynivalenol exposure induces oxidative stress and apoptosis in human keratinocytes via PI3K/Akt and MAPK signaling pathway;Environmental Toxicology;2023-09-13

3. Pharmacological PI3K inhibition in head and neck squamous cell carcinoma: A systematic review;Toxicology in Vitro;2023-04

4. Novel Ferrocene Derivatives Induce Apoptosis through Mitochondria-Dependent and Cell Cycle Arrest via PI3K/Akt/mTOR Signaling Pathway in T Cell Acute Lymphoblastic Leukemia;Cancers;2021-09-18

5. Recent insights in the PI3K/Akt pathway as a promising therapeutic target in combination with EGFR‐targeting agents to treat head and neck squamous cell carcinoma;Medicinal Research Reviews;2021-04-29